T-cell receptor alpha-beta-CD3 complex (TCRαβ-CD3)

The T-cell receptor alpha-beta-CD3 (TCRαβ-CD3) complex is a sophisticated multi-subunit transmembrane assembly found on the surface of αβ T cells, responsible for recognizing processed antigens presented by major histocompatibility complex (MHC) molecules (PMID: 31462774). The complex is composed of the highly variable TCRα and TCRβ chains, which mediate antigen specificity, and the invariant CD3 signaling subunits (CD3ε, CD3γ, CD3δ, and CD3ζ) that transduce the recognition event into intracellular signals (StatPearls: T-cell Receptors). This signaling is crucial for T-cell development, activation, and the execution of adaptive immune responses against pathogens and malignant cells. In therapeutic contexts, the TCRαβ-CD3 complex is a major target for bispecific T-cell engagers (BiTEs) that redirect T-cell cytotoxicity toward tumors, as well as for immunosuppressive antibodies used to prevent organ transplant rejection or treat autoimmune conditions like Type 1 Diabetes (PMID: 36382931). However, potent activation of this complex can lead to severe adverse events, most notably cytokine release syndrome (CRS), requiring careful clinical management (PMID: 30206114).

Other names

TCR-CD3 complexT-cell receptor complexCD3-TCR complexαβ TCR-CD3 complex

T-cell activation and redirection via bispecific antibodies, T-cell depletion or modulation via monoclonal antibodies, and antigen-specific recognition in TCR-T cell therapies.